1. Home
  2. Labeler Index
  3. Lonza Biologics, Inc.
  4. 67643-7006
  5. NDC Package Code: 67643-7006-1 Rituximab

NDC Package 67643-7006-1 Rituximab

Liquid - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
67643-7006-1
Package Description:
300000 mL in 1 TANK
Product Code:
67643-7006
Non-Proprietary Name:
Rituximab
Substance Name:
Rituximab
Usage Information:
Rituximab is used to treat certain types of cancer (such as non-Hodgkin's lymphoma, chronic lymphocytic leukemia). It works by slowing or stopping the growth of cancer cells. Some brands of rituximab are also used to treat rheumatoid arthritis and can decrease joint pain and swelling. This drug is also used to treat certain types of blood vessel disease (such as granulomatosis with polyangiitis, microscopic polyangiitis) and can decrease the swelling of the blood vessels. Rituximab is also used to treat a certain skin condition (pemphigus vulgaris). It helps to reduce the number of skin lesions. This monograph is about the following rituximab products: rituximab, rituximab-abbs, and rituximab-pvvr.
11-Digit NDC Billing Format:
67643700601
Product Type:
Drug For Further Processing
Labeler Name:
Lonza Biologics, Inc.
Dosage Form:
Liquid - A dosage form consisting of a pure chemical in its liquid1 state. This dosage form term should not be applied to solutions.
Active Ingredient(s):
RITUXIMAB 132 mg/mL
Sample Package:
N/A
Marketing Category:
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date:
11-26-1997
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Unfinished Product:
Yes
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 67643-7006-1?

The NDC Packaged Code 67643-7006-1 is assigned to an UNFINISHED drug package of 300000 ml in 1 tank of Rituximab, drug for further processing labeled by Lonza Biologics, Inc.. The product's dosage form is liquid and is administered via form.

Is NDC 67643-7006 included in the NDC Directory?

Yes, Rituximab is an UNFINISHED PRODUCT with code 67643-7006 that is active and included in the NDC Directory. The product was first marketed by Lonza Biologics, Inc. on November 26, 1997 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 67643-7006-1?

The 11-digit format is 67643700601. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-167643-7006-15-4-267643-7006-01